CN Patent

CN103232454A — 治疗精神疾病的药物

Assigned to Beijing Kaili Economic And Trade Co Ltd · Expires 2013-08-07 · 13y expired

What this patent protects

本发明涉及治疗精神疾病的药物。具体地说，本发明涉及一种原料药物，其中包括作为活性成分的说明书所述式I化合物或其药学可接受的盐：其中R1为溴，R2和R3为甲基。本发明原料药物具有良好的稳定性。

USPTO Abstract

本发明涉及治疗精神疾病的药物。具体地说，本发明涉及一种原料药物，其中包括作为活性成分的说明书所述式I化合物或其药学可接受的盐：其中R1为溴，R2和R3为甲基。本发明原料药物具有良好的稳定性。

Drugs covered by this patent

Patent Metadata

Patent number
CN103232454A
Jurisdiction
CN
Classification
—
Expires
2013-08-07
Drug substance claim
No
Drug product claim
No
Assignee
Beijing Kaili Economic And Trade Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.